Attralus Therapeutics Appoints Mark Timney as CEO and Expands Leadership Team with New Executives
Attralus, backed by venBio Partners, recruits new leadership team to support advancement of its pipeline to bring transformational pan-amyloid removal therapies to the systemic amyloidosis field May 10, 2021 07:00 AM Eastern Daylight Time SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)–Attralus Therapeutics today announced the appointment of Mark Timney as the company’s Chief Executive Officer and a member […]
